China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 16.07
-0.03 (-0.19%)
Nov 6, 2026, 3:00 PM CST
SHA:600062 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,120 | 1,914 | 2,851 | 3,462 | 2,630 | 2,834 |
Trading Asset Securities | - | 500.87 | - | - | 200.49 | 803.58 |
Cash & Short-Term Investments | 2,120 | 2,415 | 2,851 | 3,462 | 2,831 | 3,638 |
Cash Growth | -12.38% | -15.27% | -17.65% | 22.29% | -22.18% | 11.51% |
Accounts Receivable | 3,209 | 2,827 | 2,599 | 2,633 | 2,211 | 1,978 |
Other Receivables | 1,806 | 73.06 | 207.78 | 1,363 | 468.98 | 66.14 |
Receivables | 5,014 | 2,900 | 2,806 | 3,997 | 2,680 | 2,044 |
Inventory | 1,612 | 1,578 | 1,594 | 1,688 | 1,900 | 1,665 |
Prepaid Expenses | - | - | - | - | - | 0.59 |
Other Current Assets | 281.98 | 213.48 | 225.84 | 235.49 | 227.89 | 174.55 |
Total Current Assets | 9,028 | 7,107 | 7,477 | 9,382 | 7,639 | 7,523 |
Property, Plant & Equipment | 4,564 | 4,448 | 4,238 | 4,046 | 3,571 | 2,957 |
Long-Term Investments | 1,221 | 1,155 | 1,048 | 1,016 | 350.29 | 303.43 |
Goodwill | 1,077 | 1,077 | 878.49 | 907.9 | 934.96 | 788.19 |
Other Intangible Assets | 1,858 | 1,866 | 1,749 | 1,768 | 1,648 | 1,193 |
Long-Term Accounts Receivable | - | 1.56 | 2.37 | - | - | - |
Long-Term Deferred Tax Assets | 189.96 | 192.99 | 135.8 | 140.58 | 127.19 | 73.77 |
Long-Term Deferred Charges | 629.6 | 695.98 | 744.92 | 813 | 792.3 | 723.66 |
Other Long-Term Assets | 565.15 | 465.52 | 412.4 | 129.8 | 103.27 | 114.6 |
Total Assets | 19,133 | 17,009 | 16,686 | 18,203 | 15,165 | 13,676 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 909.82 | 668.98 | 835.81 | 740.49 | 750.39 | 847.4 |
Accrued Expenses | 435.55 | 1,637 | 1,673 | 1,691 | 1,496 | 1,283 |
Short-Term Debt | 50.03 | 130.95 | 99.05 | 69.47 | 36.95 | 4.75 |
Current Portion of Long-Term Debt | 85.98 | 14.25 | 12 | 200.25 | 0.27 | - |
Current Portion of Leases | - | 15.18 | 11.31 | 22.49 | 19.46 | 17.84 |
Current Income Taxes Payable | 204.78 | 40.52 | 43.84 | 65.72 | 77.78 | 59.62 |
Current Unearned Revenue | 125.86 | 198.97 | 174.88 | 293.43 | 194.21 | 201.35 |
Other Current Liabilities | 1,759 | 316.52 | 1,153 | 1,696 | 507.17 | 317.31 |
Total Current Liabilities | 3,571 | 3,022 | 4,003 | 4,779 | 3,082 | 2,731 |
Long-Term Debt | 1,736 | 1,037 | 1,090 | - | 200 | - |
Long-Term Leases | 23.34 | 14.32 | 22.1 | 29.95 | 32.93 | 35.43 |
Long-Term Unearned Revenue | 165.21 | 144.75 | 160.67 | 182.31 | 199.61 | 153.92 |
Pension & Post-Retirement Benefits | - | 163.3 | 169.64 | 147.55 | 144.18 | 157.75 |
Long-Term Deferred Tax Liabilities | 108.74 | 122.67 | 123.6 | 158.59 | 176.17 | 120.35 |
Other Long-Term Liabilities | 165.66 | 5.2 | 5.67 | 5.67 | 5.06 | 1.11 |
Total Liabilities | 5,770 | 4,509 | 5,574 | 5,303 | 3,840 | 3,199 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,039 | 1,039 | 1,039 | 1,040 | 1,043 | 1,043 |
Additional Paid-In Capital | 217.77 | 216.27 | 193.45 | 837.55 | 275.22 | 149.39 |
Retained Earnings | 11,228 | 10,426 | 9,269 | 10,460 | 9,415 | 8,718 |
Treasury Stock | -3.14 | -34.02 | -74.36 | -125.56 | -175.68 | - |
Comprehensive Income & Other | -13.32 | -13.01 | -19.3 | 1.32 | -1.43 | -5.17 |
Total Common Equity | 12,468 | 11,634 | 10,408 | 12,213 | 10,556 | 9,905 |
Minority Interest | 895.59 | 866.18 | 703.89 | 685.95 | 768.46 | 571.06 |
Shareholders' Equity | 13,364 | 12,500 | 11,112 | 12,899 | 11,325 | 10,477 |
Total Liabilities & Equity | 19,133 | 17,009 | 16,686 | 18,203 | 15,165 | 13,676 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,895 | 1,211 | 1,234 | 322.16 | 289.61 | 58.02 |
Net Cash (Debt) | 224.35 | 1,204 | 1,616 | 3,140 | 2,541 | 3,580 |
Net Cash Growth | -82.10% | -25.52% | -48.52% | 23.55% | -29.00% | 9.73% |
Net Cash Per Share | 0.22 | 1.16 | 1.57 | 3.06 | 2.45 | 3.43 |
Filing Date Shares Outstanding | 1,043 | 1,033 | 1,027 | 1,021 | 1,040 | 1,043 |
Total Common Shares Outstanding | 1,043 | 1,033 | 1,027 | 1,021 | 1,040 | 1,043 |
Working Capital | 5,457 | 4,085 | 3,474 | 4,602 | 4,556 | 4,792 |
Book Value Per Share | 11.96 | 11.26 | 10.13 | 11.96 | 10.15 | 9.49 |
Tangible Book Value | 9,534 | 8,691 | 7,780 | 9,537 | 7,973 | 7,925 |
Tangible Book Value Per Share | 9.14 | 8.41 | 7.57 | 9.34 | 7.67 | 7.60 |
Buildings | - | 3,715 | 3,452 | 3,162 | 2,579 | 2,314 |
Machinery | - | 4,690 | 4,358 | 4,000 | 3,306 | 2,758 |
Construction In Progress | - | 393.75 | 455.14 | 570.38 | 439.72 | 272.81 |